Cellular senescence entails a stable cell-cycle arrest and a pro-inflammatory secretory phenotype, which contributes to aging and age-related diseases. Obesity is associated with increased senescent cell burden and neuropsychiatric disorders, including anxiety and depression. To investigate the role of senescence in obesity-related neuropsychiatric dysfunction, we used the INK-ATTAC mouse model, from which p16 Ink4a -expressing senescent cells can be eliminated, and senolytic drugs dasatinib and quercetin. We found that obesity results in the accumulation of senescent glial cells in proximity to the lateral ventricle, a region in which adult neurogenesis occurs. Furthermore, senescent glial cells exhibit excessive fat deposits, a phenotype we termed ''accumulation of lipids in senescence.'' Clearing senescent cells from high fat-fed or leptin receptordeficient obese mice restored neurogenesis and alleviated anxiety-related behavior. Our study provides proof-of-concept evidence that senescent cells are major contributors to obesity-induced anxiety and that senolytics are a potential new therapeutic avenue for treating neuropsychiatric disorders.
In Brief
Obesity, a growing health problem in western societies, is associated with increased senescent cells and neuropsychiatric disorders, including anxiety and depression. Ogrodnik and colleagues found that clearance of senescent cells in obese mice alleviates anxiety. Our study provides proof-ofconcept evidence that senolytics are a potential new therapeutic avenue for treating neuropsychiatric disorders.
INTRODUCTION
Obesity is associated with a range of neurodegenerative and psychiatric disorders, including depression and anxiety (Gariepy et al., 2010; Hryhorczuk et al., 2013; Stunkard and Wadden, 1992) , with the latter being one of the most common behavioral traits in obese patients (Gariepy et al., 2010) . Increased anxietylike behavior has been reported in rodents genetically predisposed to develop obesity, e.g., db/db mice (Dinel et al., 2011) , and in high-fat diet (HFD)-induced obesity (Heyward et al., 2012; Mizunoya et al., 2013) . Processes such as inflammation (Capuron and Miller, 2011; Lasselin and Capuron, 2014) , altered hormone signaling (Ulrich-Lai and Ryan, 2014) , and stem cell dysfunction (Anacker and Hen, 2017; Gao et al., 2017) have been speculated to underlie obesity-related anxiety, but the underlying mechanisms have not been identified. Here, we investigate the hypothesis that anxiety-like behavior in obesity can be caused by increased senescent cell burden.
Cellular senescence is an irreversible cell-cycle arrest caused by a range of stresses, including telomere dysfunction (d'Adda di Fagagna et al., 2003) , oxidative stress (Passos et al., 2010) , inflammation (Jurk et al., 2014) , intracellular accumulation of damage (Ogrodnik et al., 2018) , and metabolic dysfunction (Wiley and Campisi, 2016) . Senescent cells display a variety of markers, including telomere-associated DNA damage foci (TAF) (Hewitt et al., 2012) , increased activity of lysosomal senescence-associated b-galactosidase (Dimri et al., 1995) , chromatin changes (senescence associated heterochromatin foci, SAHF) (Narita et al., 2003) , and frequently increased expression of the cyclin-dependent kinase inhibitor proteins, p16
Ink4a and p21 Cip1 .
While cell senescence is a potent tumor suppression mechanism (Muñ oz-Espín and Serrano, 2014) , over the long term, accumulation of senescent cells may impede the regeneration and maintenance of renewable tissues and, therefore, contribute to tissue aging. Additionally, senescent cells secrete a number of inflammatory cytokines, chemokines, and matrix proteases (the senescence associated secretory phenotype, SASP) (Coppé et al., 2008) . The SASP is thought to have evolved as a means for senescent cells to communicate with the immune system in 
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order to orchestrate senescent cell clearance and stimulate progenitor cells to repair tissues (Tchkonia et al., 2013) . However, chronic exposure to the SASP leads to damage to neighboring healthy cells, thereby contributing to tissue dysfunction during aging and in age-related diseases (Acosta et al., 2013; Nelson et al., 2012; Xu et al., 2018) .
Accumulation of senescent cells has been observed during obesity (Minamino et al., 2009; Ogrodnik et al., 2017; Schafer et al., 2016) , during aging Wang et al., 2009; Xu et al., 2015; Yousefzadeh et al., 2018) , and at the sites of pathogenesis in multiple chronic and agerelated diseases (Tchkonia et al., 2013) . Clearance of senescent cells can delay, prevent, or alleviate multiple age-related disorders (Kirkland and Tchkonia, 2017; Xu et al., 2018) . These include age-related cardiac and vascular dysfunction Roos et al., 2016) , frailty (Baar et al., 2017; Baker et al., 2016; Xu et al., 2018; Zhu et al., 2015) , hepatic steatosis , liver fibrosis (Moncsek et al., 2018) , osteoporosis (Farr et al., 2017) , osteoarthritis (Jeon et al., 2017) , and pulmonary fibrosis (Schafer et al., 2016) , among others. In the context of the brain, recent reports have shown that removing senescent cells improves phenotypes in mouse models of Parkinson's disease (Chinta et al., 2018) and tau-dependent neurodegenerative diseases (Musi et al., 2018; Bussian et al., 2018) . However, the relationship between senescence and neuropsychiatric disorders such as anxiety has not been investigated thus far.
Here, we demonstrate that in obesity, glial cells show increased markers of cellular senescence in the periventricular region of the lateral ventricle (LV), a region in close proximity to the neurogenic niche. Senescent glial cells in obese mice show excessive fat accumulation, a phenotype we termed ''accumulation of lipids in senescence'' (ALISE). Importantly, we show that clearance of senescent cells alleviates the obesity-related impairment in adult neurogenesis and decreases obesityinduced anxiety-like behavior. Our work suggests that targeting senescent cells may represent a new therapeutic avenue for treating obesity-induced neuropsychiatric dysfunction.
RESULTS

Obese Mice Show Increased Anxiety-like Behavior Not Related to Body Mass
In order to investigate the relationship between obesity and anxiety, 8-month-old C57Bl/6 mice were fed an HFD (60% of calories from fat) or standard chow diet for 2 months. As expected, we found that body weight and body fat content were increased in HFD mice in comparison to chow-fed controls (Figures S1A and S1B). To measure anxiety-like behavior, we first employed the open-field (OF) test. This test evaluates the tendency of mice to remain close to the walls and avoid open spaces (central zone), a phenomenon known as thigmotaxis, which is widely used as an indication of anxiety-like behavior (Simon et al., 1994) . HFD-fed mice were less inclined to explore the central area of the OF test chamber than the peripheral zone , and likewise the total distance covered was significantly decreased in HFD animals during the test (Figure S1C) . To account for decreased activity in obese animals, anxiety measurements were analyzed as a function of the total distance traveled during experimental testing (Figures 1B and 1D) . As it has been shown that obesity impacts activity and exploratory behavior and contributes to anxiety-like behavior (Friend et al., 2017; Guillemot-Legris and Muccioli, 2017) , we next investigated if body weight and body composition alone could explain the observed anxiety-like behavior. Linear regression analysis revealed no significant correlation between body weight or percentage of fat mass with anxiety-like behavior in HFD-fed mice ( Figures 1D, 1E , and S1E-SIJ). This indicates that while weight gain is associated with the onset of anxietylike behavior, once a certain weight is reached, no correlation between weight and anxiety is found, which suggests that factors apart from weight gain must play a role.
As an additional measurement of anxiety-like behavior, we used the elevated plus maze (EPM) test. The EPM is based on the animals' natural fear of heights and open spaces. Increased anxiety-like behavior in the EPM test is manifested as a decrease in the number of head-pokes and entries into the open arms. We found that animals on the HFD had decreased entries into the open arms of the EPM (frequency and time) compared to lean animals ( Figures 1F-1H ), which is indicative of increased anxiety-like behavior. Similar to the OF test, there were no significant correlations between body and fat mass and anxiety parameters in either lean or HFD-fed animals ( Figures 1I, 1J , S1K, and S1L).
Pharmacogenetic and Pharmacologic Clearance of Senescent Cells Alleviates Obesity-Related Behavioral Changes
Several recent reports have demonstrated that the removal of senescent cells can alleviate a large array of age-related disorders (Kirkland and Tchkonia, 2017) . Obesity has been associated with the accumulation of senescent cells in fat tissue (Minamino et al., 2009; Schafer et al., 2016; Tchkonia et al., 2010) and the liver . However, a link between obesity-induced senescence and anxiety has not been investigated. Therefore, we investigated whether senescent cells may contribute to anxiety-like behavior during obesity by using the INK-ATTAC mouse model. This model allows the selective suicide gene-mediated ablation of highly p16
Ink4a
-expressing cells, many of which are senescent, upon administration of the drug AP20187 (AP), which cross-links the ATTAC fusion protein, thereby activating its caspase 8 moiety to induce apoptosis Xu et al., 2015) .
We repeatedly treated chow-and HFD-fed 10-month-old mice with AP or vehicle (Figure 2A ) over the duration of 10 weeks, which resulted in no significant changes in body weight (Figure S2A) or body composition (data not shown). To measure anxiety-like behavior, we first used the OF test and confirmed our previous observation that animals on the HFD were less inclined to explore the center of the open field chamber than the periphery, as measured by the distance traveled ( Figure 2C ) and entries ( Figure 2D ) into the central zone. Furthermore, HFD-fed mice traveled significantly less throughout the duration of the tests, covering a smaller total distance ( Figure S2C ). To take this into account, most measured parameters (as indicated) were expressed as a function of the total distance traveled. Clearance of p16
Ink4a -positive cells with AP reduced HFD-induced anxiety-like behavior as measured by distance covered in the central zone (Figures 2B and S2B) and entries into the central zone (Figure 2C ). However, AP treatment did not affect the total distance traveled ( Figure S2C ) or any of the aforementioned parameters in the chow-fed mice . Next, we assessed anxiety-like behavior with the EPM. As previously noted, obese animals avoided entries into the open arms To exclude off-target effects of the drug AP, wild-type C57Bl/6 mice were treated with the drug and tested for anxiety-like behavior. Consistent with previous studies, wild-type mice showed a significant difference between chow and HFD in the OF test before the start of the treatment ( Figure S2H ), but no difference was observed in the HFD-fed mice after treatment with AP ( Figure S2I ).
In addition to the HFD-fed mice, we conducted complementary experiments in db/db mice in which obesity is caused by a point mutation in the leptin receptor gene lepr, leading to spontaneous type 2 diabetes (Wang et al., 2014) . We treated these mice intermittently for 2 months with the senolytic drug cocktail, Dasatinib and Quercetin (D+Q) (Zhu et al., 2015) . db/db mice have significantly increased body weights and adipose depot weights when compared to lean db +/À heterozygous littermates, but interestingly, body weight did not change over the course of D+Q treatment ( Figures S2J and S2K ). Similar to HFD-fed mice, db/db mice exhibited increased anxiety-like behavior as assessed by the OF test ( Figures 2H-2J ). We observed that the total distance covered ( Figure 2I ) and the number of entries ( Figure 2J) Figures 2K and 2L ). To exclude off-target effects of the drug AP, db/db mice were treated with AP and no off-target effects on anxiety-like behavior were observed in OF testing ( Figure S2P ). Similar to our previous observations, linear regression analysis showed no significant correlations between body weight and anxiety-like behavior in HFD-fed INK-ATTAC (with and without AP) or db/db (with or without AP or D+Q) mice ( Figures S2Q-S2S ).
In conclusion, our data show that pharmacological or pharmacogenetic clearance of senescent cells in two different models of obesity significantly alleviates anxiety-like behavior.
Pharmacological and Pharmacogenetic Senolytic Approaches Reduce Senescent Cell Burden and Alleviate Systemic Inflammation
To investigate the effectiveness of senescent cell clearance in HFD mice, we measured senescence markers in the perigonadal adipose tissue, a tissue previously shown to exhibit a marked increase in the number of senescent cells with age (Schafer et al., 2016; Tchkonia et al., 2010; Xu et al., 2015) .
We found that the senescence markers SA-b-Gal, p16, and TAF were increased in INK-ATTAC mice on HFD and were significantly reduced upon administration of AP ( Figures 3A-3C ). p21 and g-H2A.X were increased in HFD animals but were not significantly changed after AP treatment ( Figures S3A and S3B) . Similarly, we found that db/db mice had an increased burden of senescent cells in perigonadal fat (measured by SA-b-Gal and TAF frequency) compared to db/db +/À mice. This was significantly reduced by treatment with the senolytic cocktail, D+Q ( Figures 3D-3F ).
Given that the senolytic approaches we applied act systemically, it is possible that they reduce pro-inflammatory SASP factors that can penetrate the blood-brain barrier and therefore impact the brain. To investigate this possibility, we analyzed blood plasma for a large array of SASP factors. Evaluation of circulating cytokines in the bloodstream of chow-and HFD-fed INK-ATTAC mice revealed that HFD resulted in the up-regulation of known SASP factors such as G-Csf, Il-1a and Il-1b, Kc/Cxcl1, Mcp-1, Mig, and Tnf-a, which were then downregulated upon AP treatment ( Figure 3G ). Similarly, SASP factors in the blood plasma of db/db mice were increased in comparison to lean db/db +/À littermates and reduced after treatment with D+Q (Figure 3H ). As peripherally derived cytokines have been shown to inhibit neurogenesis and to drive anxiety and depression (Anacker and Hen, 2017; Gao et al., 2017; Li et al., 2014) , we correlated the expression of cytokines in the bloodstream with parameters of anxiety-like behavior measured by OF testing. We observed significant negative correlations between the plasma levels of Cxcl1, G-Csf, and Mig and different anxietylike measurements in AP-treated HFD mice (Figures 3I-3K and S3C) and D+Q-treated db/db mice ( Figures S3D and S3E ), whereas no correlation was found for Tnf-a, . These results led us to further investigate the impact of systemic factors on the observed anxiety phenotype. As Cxcl1 is the cytokine that best correlates with anxiety-like behavior and has been previously associated with obesity (Nunemaker et al., 2014), we injected lean animals with recombinant murine Cxcl1. As expected, injection of Cxcl1 led to increased levels of circulating Cxcl1 ( Figure S3I ). Additionally, increased plasma Cxcl1 resulted in a slight decrease in body weight but did not alter body composition (Figures S3J and S3K) . Examination of anxiety-like behavior using the OF ( Figure S3L ) and EPM ( Figure S3M ) tests showed no difference between treated and non-treated animals. To further examine the role of Cxcl1 in anxiety-like behavior, we treated HFD mice with reparixin, which inhibits the Cxcl1 receptors Cxcr1 and Cxcr2. Mice on reparixin had a small increase in body weight ( Figure S3N ), but no difference in body fat ( Figure S3O ), in comparison to non-treated mice. Again, we observed no difference in behavior between the treated and non-treated groups when animals were tested in the OF box ( Figure S3P ) or the EPM ( Figure S3Q ). These results suggest that Cxcl1 alone is not sufficient to induce an anxietylike phenotype; however, they do not exclude the possibility that other soluble SASP factors are involved in the process. Recently, it has been shown that transplantation of relatively low numbers of senescent cells in young animals resulted in physical dysfunction measured by Rotarod performance, grip strength, or endurance compared to the transplantation of non-senescent cells (Xu et al., 2018) . Importantly, this study showed that the transplantation of senescent cells resulted in long-lasting systemic effects in tissues located distantly from where senescent cells were injected.
To test the hypothesis that senescent cells can induce anxietylike behavior via systemic effects, we transplanted senescent or non-senescent cells into lean mice and assessed behavior and physical function 6 and 12 weeks later ( Figure S3R ). We confirmed our previous observations that transplanted senescent cells reduced physical function (Xu et al., 2018) , as measured by Rotarod ( Figure S3S ), but had no effect on anxiety-like behavior using the OF test ( Figures S3T-S3W ). Together, these experiments suggest that presence of senescent cells elsewhere in the body is not sufficient to induce an anxiety-like phenotype in mice.
Senolytic Treatment Reduces the Frequency of Senescent Cells in the Amygdala and Hypothalamus, but Not in Other Regions of the Brain
Our previous results led us to hypothesize that obesity could induce senescence specifically in the brain, thereby contributing to an anxiety-like phenotype. Given the reported occurrence of senescence markers in neurons and glial cells of aging mice in the cortex, cerebellum, and hippocampus Kang et al., 2015) , we first assessed markers of senescence in these regions of the brains of obese and lean INK-ATTAC mice treated with and without AP. We found no differences in the senescent markers p21, p16, gH2A.X, or TAF among any of the experimental groups ( Figures S4A-S4D ). This is consistent with the absence of differences in memory and learning among any of the experimental groups as assessed by Stone's maze (Figures S2F and S2G) .
Interestingly, assessment of senescent cells in the amygdala, a region of brain associated with emotional responses such as anxiety and fear (Adhikari et al., 2015) , revealed a significant increase in the number of p16
Ink4a -positive cells in HFD-fed mice ( Figure 4A ). TAF-positive neurons in the basomedial layer of the amygdala were significantly increased in HFD mice and significantly decreased by treatment with AP ( Figures 4B-4D were significantly increased in HFD compared to lean mice and were significantly decreased by treatment of HFD-fed mice with AP. Together, these data indicate that HFD does not induce senescence in regions of the brain implicated in learning, memory, or motor neuron control such as the cortex, cerebellum, and hippocampus. However, HFD induces senescence in the hypothalamus and amygdala, which may contribute to its effects on anxiety-like behavior, and treatment with AP reduced senescent cell abundance and attenuated these behavioral changes.
Clearance of Senescent Cells Decreases Periventricular Accumulation of Lipid-Laden Glia in Obese Animals
Senescent cells have been shown to accumulate in obesity (Minamino et al., 2009; Ogrodnik et al., 2017; Schafer et al., 2016; Tchkonia et al., 2010) , and their prevalence has been related to the accumulation of ectopic fat . Recently, it has been reported that cells accumulating lipid droplets in the brain occur in close proximity to the ventricles, and the number of these cells increases in mice with age (Shimabukuro et al., 2016) , in Alzheimer's disease (AD) patients, and in mouse models of AD (Hamilton et al., 2015) . These data led us to investigate the connection between senescence and fat accumulation in the brain.
Analysis of perilipin 2 (Plin2) expression (a protein that surrounds lipid droplets) in the brain of HFD-fed mice revealed a significant increase in Plin2 + cells ( Figure S5A ) located in close proximity to the LV compared to chow-fed controls (Figures 5A and 5B Figure 5E ), while the total DNA damage did not change ( Figure S5C ). Together, our findings indicate that a HFD contributes to increased numbers of senescent cells in the periventricular region of the brain and that these cells preferentially accumulate fat. Given that we previously observed a similar phenomenon in senescent hepatocytes and fibroblasts , we termed this phenotype ''accumulation of lipids in senescence'' (ALISE).
To further investigate the impact of senescent cells on the buildup of fat in the brain, we used the INK-ATTAC mouse model . Treatment of HFD-fed INK-ATTAC mice with AP resulted in a significant reduction of Plin2 + cells (Figures 5F and 5G), as well as cells bearing senescence markers ( Figure 5H ). Furthermore, we analyzed the area occupied by lipid droplets in ependymal cells and the senescence marker TAF in glia in close proximity to the LV of db/db animals. We found that these were significantly increased in db/db in comparison to db/db À/+ animals and significantly reduced after treatment with the senolytic cocktail, D+Q ( Figures S5D-S5F ). Additionally, we assessed neuroinflammation by conducting RNA in situ hybridization Data are from n = 6-9 mice per group for (A)-(C) and (G); n = 7-12 mice per group for (E), (F), and (H); n = 27 mice per group for (I)-(K). Mean ± SEM plotted. *p % 0.05 and **p % 0.001.
against the SASP factors Cxcl1 and Il-6 in combination with immunostaining for Plin2 in close proximity to the LV of HFD mice ( Figure 5I ). Interestingly, we found that more than 80% of Plin2 + cells were also positive for Cxcl1 and Il-6 (Figures 5J and 5K).
Finally, anxiety markers in HFD animals, such as distance traveled in the central zone and entries into the central zone, were strongly negatively correlated with the abundance of Plin2 + cells in close proximity to the LV ( Figures 5L and 5M ). Together, these data support a causal link between the accumulation of lipidladen senescent glial cells in obese animals and anxiety-like behavior.
Suppression of the ALISE Phenotype Reduces Accumulation of Cytosolic Chromatin Fragments and the SASP To further investigate the impact of fat accumulation on cell senescence, we used mouse adult fibroblasts (MAFs) and induced senescence by X-ray irradiation as previously described (Jurk et al., 2014; Ogrodnik et al., 2017 (Ivanov et al., 2013) , which activate the DNA-sensing cGAS-STING pathway, a major driver of the SASP (Dou et al., 2017) . Interestingly, we found that abrogation of the ALISE phenotype significantly reduced CCF in senescent cells (Figures 6C and 6D) , but not the average number of DNA damage foci ( Figures 6E and 6F ) or bi-nuclearity ( Figure S6A ). Consistent with the hypothesis that enhanced lipid deposition impacts CCF and the SASP, we found that depriving cells of lipids resulted in a drastic reduction of several key components of the SASP, such as Il-6, Kc (Cxcl-1), Ip-10 (Cxcl-10), and Lix (Cxcl-5) ( Figures 6G-6K ). To investigate if these findings were restricted to MAFs, we conducted similar experiments in primary mouse astrocytes. Similar to MAFs, we found an increased buildup of fat, increased TAF, and higher numbers of CCF in senescent astrocytes ( Figures 6L-6O ).
Based on these data, we propose that excessive ALISE may be a contributor of genomic instability, resulting in the release of chromatin fragments and activation of the SASP. (legend continued on next page) Impaired Neurogenesis in HFD Animals Is Rescued by Clearance of Senescent Cells Ectopic buildup of lipid droplets in AD brains has been shown to induce dysfunction of neural stem cells residing within the subventricular zone (SVZ), suppress adult neurogenesis, and cause cognitive impairment (Hamilton et al., 2015) . In HFD mice, we observed that Plin2 + senescent glial cells are frequently found in close proximity to cells expressing doublecortin (Dcx), a marker of neuronal precursor cells and immature neurons ( Figure S7A ). Thus, we hypothesized that the presence of ALISE glial cells could impair adult neurogenesis in the SVZ.
To test this hypothesis, we treated lean and obese INK-ATTAC mice with or without AP, as previously described. Following organ harvesting, we obtained single-cell suspensions from one brain hemisphere and analyzed them by cytometry by time of flight (CyTOF), which allows for mapping and discriminating between different brain cells including astrocytes, oligodendrocytes, microglia, neurons, ependymal cells, pericytes, and endothelial cells. We reserved the second brain hemisphere for histological analyses ( Figures 7A and 7B) .
We ) were all significantly up-regulated after senolytic treatment with D+Q ( Figures S7N-S7P) .
We validated these findings by performing immunostaining for Dcx ( Figures 7H and 7I ) in the olfactory bulb and EdU-pulse labeling ( Figures S7S and S7T Figures S7G-S7I ) in obese animals, whereas no differences between lean and obese animals were detected. This finding was further confirmed by immunostaining for Gfap ( Figures S7Q and S7R ) and may be related to increased brain plasticity supporting neurogenesis (Choi et al., 2016) . Finally, we found that the frequencies of Plin2 + glia negatively correlated with the markers of ependymal cells and markers of adult neurogenesis, Nestin + ( Figure 7K ) and Dcx + ( Figure 7L ). Similarly, individual differences in the distance traveled in the central area were positively correlated with the frequencies of Dcx + and Nestin + cells ( Figures 7M  and 7N) .
In summary, our data indicate that senescent cells play a causal role in the impaired neurogenesis induced by obesity. Targeting senescent cells in obese mice alleviates obesityrelated anxiety-like behavior as a result of the clearance of periventricular fat accumulation and restoration of adult neurogenesis.
DISCUSSION
Obesity is a complex disorder and a major risk factor for many diseases and health problems, including heart disease, diabetes, stroke, high blood pressure, cancer, osteoarthritis, and cognitive impairment (Frasca et al., 2017) . Additionally, decreased spatial memory, anxiety, and depression have been linked to obesity-associated brain inflammation (Guillemot-Legris and Muccioli, 2017). Previous studies have reported that HFD-and genetically induced obesity in mice results in anxiety-like behavior (Dinel et al., 2011; Heyward et al., 2012; Mizunoya et al., 2013) . However, similar to other obesity-driven phenotypes such as physical inactivity (Friend et al., 2017) , anxiety-like behavior is not simply caused by increased body mass. Interestingly, loss of body weight alone does not always correspond to improvements in mental health, e.g., after bariatric surgery (Canetti et al., 2016; Cunningham et al., 2012; Fisher et al., 2017; Kouidrat et al., 2017; Matini et al., 2014 ). Thus, the 
(legend on next page)
mechanistic basis of obesity-induced anxiety-like behavior is not yet fully understood. HFD induces senescence in multiple organs, predominantly in perigonadal adipose tissue (Schafer et al., 2016; Tchkonia et al., 2010; Xu et al., 2015) but also in other organs including the liver . Until now, the role of HFD in the induction of senescence in the brain is largely understudied. Recently, several studies have uncovered a role for senescent glial cells in neurodegenerative diseases such as tau-dependent pathology and Parkinson's disease (Bussian et al., 2018; Chinta et al., 2018; Musi et al., 2018) .
Our data demonstrating a link between obesity, senescence, and anxiety-like behavior provide critical support for the potential feasibility of administering senolytics to treat obesity-associated anxiety-like behavior, provided that clinical trials validate this approach.
It should be mentioned that our experimental strategy does not distinguish which senescent cell types are responsible for inducing anxiety-like behavior. However, we found that senescent, pro-inflammatory glial cells are frequently found in close proximity to areas in the brain expressing markers of neuronal precursor cells and immature neurons, which suggests that they may exert negative effects on stem cells. While senescence can impact stem cells in a cell-autonomous fashion by affecting their proliferation and differentiation (Xu et al., 2015) , it had been previously suggested that senescence can impact stem cells non-autonomously via the SASP (Krtolica et al., 2011; Pricola et al., 2009) . Consistent with this hypothesis, we found that SASP factors in blood plasma and specifically in the brain were increased during obesity and significantly reduced following both the pharmacogenetic and pharmacological clearance of senescent cells. Nonetheless, neither injection of the major SASP factor Cxcl1 (which increased during obesity) nor inhibition of its receptors had an impact on anxiety-like behavior. Additionally, transplantation of senescent cells, which has been previously shown to induce systemic effects and result in long-lasting physical dysfunction in mice, did not have an impact on anxiety-like behavior. These data suggest that anxiety-like phenotypes driven by obesity may be a consequence of senescence occurring locally in specific regions of the brain. However, given the fact that there are as yet no means to eliminate senescent cells from specific regions of the brain, this hypothesis remains highly speculative.
Dysfunction of peripheral (Ambrosi et al., 2017; Cignarelli et al., 2012; Matsushita and Dzau, 2017) and neural stem cells (Li et al., 2014) has been linked to obesity and metabolic syndrome and inflammation and have been postulated to be among the factors connecting adult neural stem cell dysfunction to obesity (Li et al., 2014) . Nevertheless, the underlying mechanisms remain unclear. We previously reported that reducing the abundance of senescent cells that accumulate with aging restores adipose (Xu et al., 2015) and bone stem cell function (Farr et al., 2017) . Similarly, others have reported improvement in hematopoietic and hair follicle stem cell function (Chang et al., 2016; Yosef et al., 2016) and neurogenesis in a model of Parkinson's disease (Chinta et al., 2018) following various senolytic treatments. Here, using CyTOF and EdU-pulse labeling, we demonstrate that clearing senescent cells in obese mice partially restores the neural stem cell pool.
A link between anxiety-like behavior in mice and neural stem cell function has been previously established (Drew and Huckleberry, 2017; Siopi et al., 2016) . Our data suggest that the subventricular zone-olfactory bulb axis is involved in the therapeutic effects of senescent cell clearance. Functional inactivation of the main olfactory epithelium was shown to be sufficient to induce anxiety-like behavior in mice (Glinka et al., 2012) . Additionally, adults with a history of childhood stress or major depressive disorders show reduced olfactory bulb volume (Croy et al., 2013; Negoias et al., 2010) .
Although we show that expression of neurogenesis markers is negatively associated with anxiety-like behavior, we cannot exclude the possibility that it is anxiety itself that impairs neurogenesis. In a recent study, chronic corticosterone administration was shown to contribute to anxiety and depression and was sufficient to induce olfactory deficits and impair adult neurogenesis (Siopi et al., 2016) .
In our study, we also made the novel observation that senescent glial cells accumulate lipids, a phenotype that also occurs in senescent fibroblasts and astrocytes cultured in vitro, which we termed ALISE. Hamilton et al. (2015) have shown that the accumulation of lipid droplets in the SVZ occurs in mouse models of AD and human AD patients. They also reported that these lipids are derived from the cerebrospinal fluid and that the presence of lipid droplets is associated with neuronal stem cell dysfunction in a mouse model of AD (Hamilton et al., 2015) . Our data show that it is the presence of lipid-containing senescent cells, rather than accumulation of lipids per se, that contributes to impaired neurogenesis. Our data imply that it is the elimination of senescent cells, rather than the reduction of lipid availability, that improves neurogenesis and alleviates mouse anxiety-like behavior.
Mechanistically, lipid accumulation in senescent cells has been related to mitochondrial dysfunction and impaired fatty acid oxidation . Recent data have shown that mitochondrial dysfunction during senescence is a key effector of cellular senescence, playing a role in the stabilization of the growth arrest (Passos et al., 2010) and the induction of the SASP (Correia-Melo et al., 2016) . Based on these findings and our data, we speculate that when lipids are available, senescent cells cannot effectively metabolize them, which in turn results in increased genomic instability, release of CCF, and induction of the SASP.
Despite increasing evidence that anxiety is associated with decreased quality of life, increased depression, and suicide in obesity (Wagner et al., 2013) , there are currently no mechanism-based treatments available. Here, we show that cellular senescence provides a potential explanation for increased anxiety in obese individuals and that targeting senescent cells holds promise as a therapeutic strategy.
Limitations of Study
While our study shows that senescent cells have an impact on anxiety, our experimental strategy was not capable of distinguishing which senescent cell types are responsible. Further studies using animal models where senescent cells can be cleared in a cell-type specific manner will be able to address this particular pitfall. Obesity does impact locomotion (obese animals move more slowly and tend to freeze more), which may induce some artifacts to the analysis of anxiety-like behavior. Future studies may use non-locomotion-based assays such as marble burying.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Diana Jurk (jurk.diana@mayo.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Experimental procedures were approved by the Institutional Animal Care and Use Committee at Mayo Clinic (protocol A26415). INK-ATTAC +/-transgenic mice were generated and genotyped as previously described ) based on experimental strategies devised by J.L.K., T.T., J. van Deursen and D. Baker at Mayo Clinic. Briefly, INK-ATTAC mice were produced and phenotyped at Mayo Clinic. Controls for the INK-ATTAC experiments were INK-ATTAC-null C57BL/6 background mice raised in parallel. C57BL/6 db/db and db/+ mice were purchased from Jackson Laboratories. Mice were housed 2-5 mice per cage, at 22 +/-0.5 C on a 12-12 hour day-night cycle and provided with food and water ad libitum. Cages and bedding (autoclaved Enrich-o'Cobs (The Andersons Incorporated)) were changed once per week. For high fat dietinduced obesity studies, mice were randomly assigned to chow-or HFD-fed groups. Mice were fed the high fat diet for 2-4 months before experiments started. High fat food was purchased from Research Diets (cat no #D12492). 60% of calories in this high fat diet are from fat. Standard mouse chow diet was obtained from Lab Diet (cat no #5053). In all the experiments littermates of the same sex were randomly assigned to experimental groups.
INK-ATTAC mice were injected intraperitoneally (i.p.) with AP20187 (10mg/kg) (MCE MedchemExpress; Cat: # HY-13992/CS-1953) or vehicle (4% ethanol, 10% PEG-400, and 2% Tween-20 in distilled water) for 3 days every 2 weeks for a total of 8-10 weeks.
Continued
METHOD DETAILS
Senescent and Young Cells' Transplantation Wild-type C57BL/6 mice were obtained from the National Institute on Aging (NIA) and maintained in a pathogen-free facility at 23-24 C under a 12h light, 12h dark regimen with food and water ad libitum. Cell transplantation was done as previously described (Xu et al., 2018) . Briefly, 18 month old mice were anesthetized using isoflurane and were injected intraperitoneally with 150ml PBS through a 22-G needle containing 10 6 non-senescent control or senescent mouse preadipocytes or only PBS. Preadipocytes were obtained from inguinal fat from young luciferase-expressing transgenic C57BL/6 mice from the Jackson Laboratory Harbor, (Bar, ME; stock no. 025854). Senescence was induced by 10 Gy cesium radiation. Open field testing was carried out 2 and 6 weeks after transplantation and Rotarod performance was tested 2 and 12 weeks after transplantation.
Body Composition
Lean and fat masses of individual mice were determined by quantitative nuclear magnetic resonance using an EchoMRI analyser (Houston, TX) and expressed as a function of body weight. Un-anesthetized animals were placed in a plastic tube that was introduced into the EchoMRI instrument. Body composition, comprising fat mass and lean mass, was determined in approximately 90 seconds per animal.
Open Field Testing
Locomotor activity and anxiety-like behavior of mice were assessed in sound-insulated, rectangular activity chambers (Med Associates, St Albans, VT, USA: W3L3D = 27cm327cm320cm with continually running fans, infrared lasers, and sensors). Beam breaks were assessed in 2-min bins over 30 min, converted automatically to current mouse location and distance travelled (cm), and recorded on a computer with Med-PC software Version 4.0. Before the test, mice were acclimatized to the room for 1-1.5h before being introduced into the chambers. Mice were habituated for 5 min in the Open Field chamber (without recording) then placed for another 5 min in the home cage. Afterwards, mice were introduced back to the chambers and all mouse movements were recorded for 30 min. Anxiety was quantified by the distance mice travelled in the central 25% of the chamber (zone 1) as a function of the total distance mice travelled and by frequencies of entries into zone 1. 
Elevated Plus Maze
Rotarod
The Rotarod performance test evaluates mouse balance and motor coordination. Mice were brought to the test room a day before testing and habituated overnight. For the baseline tests, mice were first trained on Rotarod (3375-M5; TSE systems) for three consecutive days. Mice were placed (having their back turned towards the experimenter) on the rotating rod of 4.0cm diameter. Mice trained to stay on the rod for 200sec at one constant speed per day, increasing the speed each day from 4rpm, 6rpm, to 8rpm. If a mouse fell during training, it was put back on the rod. For the test on the fourth day, the Rotarod was started at 4rpm and steadily accelerated to 40rpm over a 5 min interval. The speeds at which mice dropped were recorded in 4 consecutive trials. Two and 12 weeks after baseline measurements, mice were tested again, habituating overnight prior to the test day. The average was normalized to the baseline and taken as an indicator of mouse balance and motor coordination.
Stone's T-Maze
A water-motivated version of the Stone's T-maze was used to measure murine short-term memory. A straight run (for pre-training) or Stone's T-maze were placed into a steel pan filled with water to a depth of approximately 3 cm so that half the height of the interior walls of the maze were underwater. The ceilings of both the straight run and the maze were covered with clear acrylic to prevent mice from rearing out of the water. These dimensions created a situation that enables the mice to maintain contact with the floor while keeping their heads above water. The mice were placed into a start box and were pushed into the maze using a sliding panel. At the end of the straight run or the maze there was a goal box that contains a ramp to a dry floor, which allows the mice to escape from the water upon successful completion of the straight run or the maze. On day one, mice underwent straight run training to establish the concept that moving forward allows them to escape the water by reaching a water-free goal box. Successful completion of this phase requires the mice to reach the goal box in 10 seconds or faster in 8 out of 10 trials. Mice that did not reach this criterion were excluded from further testing. Maze training commenced the following day. Mice had to complete 9 maze acquisition trials in a single day. All mice per group performed one trial before performing the next one. Runs using between 6 and 8 mice resulted in inter-trial intervals (ITI) of approximately 5-12 minutes. During ITI, mice were placed in a holding cage containing a dry towel that was additionally heated by a red heat lamp. Primary measures of learning and memory were the latency to reach the goal box and the numbers of errors committed. An error was defined as complete entry of the mouse's head or the whole body into an incorrect path. During the acquisition phase, if any mouse failed to reach the goal box within 5 minutes, the trial was terminated and scored as a failure. Any mouse having 3 failures was removed from further trials. None of the mice was excluded from this study. 
RT-PCR
EdU Experiments
For EdU experiments, HFD and control chow-fed INK-ATTAC mice treated with AP were injected with EdU (Life Technologies; Cat: #E10187) at a dose 123 mg/kg with the final concentration of 6.15mg/mL, dissolved in sterile PBS (pH 7.4, Fisher Scientific), 2 hours before perfusion. There was a 15min interval between mouse injections to allow for time needed to perfuse each mouse. The animals were deeply anesthetized with 90mg/kg ketamine and 10mg/kg of xylazine in sterile PBS prior perfusion. Transcardiac perfusion with PBS was followed by perfusion with 4% paraformaldehyde in PBS chilled on ice. Brains were harvested and postfixed overnight in 4% paraformaldehyde in PBS at 4 C, washed with PBS, and stored at 4 C for vibratome sectioning. Sagittal brain sections of 50mm were cut on a vibratome and collected sequentially in 6 different plate wells, total of 13 sections, 250mm apart in each well, representing 1/6 of the brain hemisphere. Sections were stained free-floating in 12-well plates, with all procedures being performed at room temperature at a volume of 500ml in each well. Sections were initially permeabilized in 4% Triton X-100 (Sigma-Aldrich) in PBS for 1h with 3 subsequent PBS washes. Click reaction was performed for EdU visualization, including 20mM (+)-sodium L-ascorbate (Sigma-Aldrich), 10mM Alexa 555-azide (Life Technologies), and 4mM copper sulfate (Sigma-Aldrich) in PBS. Sections were incubated with gentle shaking for 15min followed by PBS washing. Brain sections were collected and placed on gelatinized glass slides. All preparations were mounted with fluorescent mounting medium (DAKO) and coverslipped.
For assessment of hippocampal neurogenesis, EdU + cells slides were imaged using a Leica DM5500B fluorescence microscope with in depth Z stacking. Cells were manually counted in the basal layer of the dentate gyrus in all 13 sections and multiplied by 6 to obtain an estimate of the number of dividing cells per hemisphere.
For assessment of neurogenesis in the subventricular zone (SVZ), 13 sagittal, 50mm-thick sections were imaged using a Leica DM5500B fluorescence microscope. In depth Z stacking was used (images were captured as stacks separated by 4mm with a 10x objective). Quantity of positive cells was manually counted in the ventral SVZ using ImageJ and the total number of cells was normalized to the number of images taken.
Immunostaining and Telomere-Associated Foci (TAF) and Quantification Paraffin sections were deparaffinized with Histoclear and hydrated in an ethanol gradient followed by water and PBS. Antigen was retrieved by incubation in 0.01M citrate buffer (pH 6.0) at 95 C for 10min. Slides were placed in blocking buffer (1:60 normal goat serum [S-1000, Vector Laboratories] in 0.1% BSA/PBS) for 60min at room temperature. For TAF staining, slides were additionally blocked with Avidin/Biotin (Vector Lab, #SP-2001) for 15min each. Primary antibodies used (table below) were diluted in blocking buffer and applied overnight at 4 C. The next day, slides were washed 3 times with PBS and incubated for 30min with secondary goat, anti-rabbit antibody (1:200; Vector Laboratories #BA-1000) for TAF staining or for 60min with secondary Alexa antibody (table  above) . For TAF staining, Fluorescein-Avidin in PBS (1:500; #A-2011, Vector Lab) was applied to each sample for 20min. Slides were washed 3 times in PBS, which was followed by FISH for TAF detection. Briefly, tissues were crosslinked with 4% paraformaldehyde for 20min and dehydrated in graded ethanol. Sections were denatured for 10min at 80 C in hybridization buffer (70% formamide (Sigma), 25mM MgCl 2 , 0.1M Tris (pH 7.2), and 5% blocking reagent [Roche]) containing 2.5mg ml -1 Cy-3-labelled telomere-specific (CCCTAA) peptide nucleic acid probe (Panagene), followed by hybridization for 2h at room temperature in the dark. Slides were washed twice with 70% formamide in 23SSC for 15min, followed by washes in 23SSC and PBS for 10min. Sections were mounted in Vectashield DAPI-containing mounting media and imaged.
A single, 3mm-thick section per mouse was used for TAF staining, while Dcx and Plin2 staining was performed 80mm-apart on three 10mm-thick sections. To quantify periventricular lipid accumulation, 10-30 images in the periventricular region were taken using a DM5500 widefield fluorescence microscope from Leica with a 10x (for frequency of ALISE-positive periventricular glia) or x40 (for assessment of ALISE phenotype of ependymal cells) objective lens. Number of Plin2-positive cells (for frequency of ALISE-positive periventricular glia) or area of Plin2-positive vesicles (for ALISE phenotype of ependymal cells) was assessed using ImageJ software. For assessment of identity of Plin2+ cells, 10mm-thick sections were stained with a combination of antibodies for Iba1 (secondary antibody conjugated with Alexa Fluor 488), Plin2 (secondary antibody conjugated with Alexa Fluor 594), and vimentin (secondary antibody conjugated with Alexa Fluor 647) and quantified for frequency of Plin2+ astrocytes (Iba1-, Vim+) and microglia (Iba1+) in the periventricular region. Separate staining for Plin2 (secondary antibody conjugated with Alexa Fluor 594) and NeuN (secondary antibody conjugated with Alexa Fluor 647) were used to determine frequency of Plin2+ neurons in periventricular region. For TAF quantification, in depth Z stacking was used (images were captured as stacks separated by 0.4 mm with 363 objective) followed by ImageJ analysis.
Serum levels of the cytokines Eotaxin, G-Csf, Tnf-a, Il-6, Ifn-g, Il-1a, Il-1b, Il-17, Il-2, Kc/Cxcl1, Mcp-1, M-Csf, Mig, Mip-1a, and Mip-1b were determined using a Multiplexing LASER Bead Assay (Mouse Cytokine Array / Chemokine Array 31-Plex (MD31), Eve Technologies; Canada). Blood was withdrawn from mice by puncturing the sub-mandibular vein on the day of dissection before an animal was sacrificed. 50mL of serum was shipped to Eve Technologies on dry ice. Due to high variability of data, an unbiased elimination of outliers was performed using ROUT's method (Graphpad 7 Prism). The same panel was used to detect SASP-factors in MAF and 50ml of media were shipped to Eve Technologies on dry ice.
Immuno-and Nile Red Staining for MAFs and Astrocytes
IHC for GFAP Tissue distribution of glial fibrillary acidic protein (GFAP) in the brain was assessed by immunohistochemistry using an image analysis workstation after staining with antibodies. The brain sections were pretreated with 0.3% H 2 O 2 methanol for 1h at room temperature and with normal goat serum for 1h at room temperature. Each specimen was incubated with the primary antibody overnight at 4 C. The primary antibody used in this study and the dilutions were as follows: rabbit anti-cow glial fibrillary acidic protein (GFAP) [1:800, DAKO, Denmark]. Immunohistochemistry was performed using the VECTASTAIN ABC System (Vector Laboratories, Burlingame, CA) with the avidin/biotin peroxidase complex (ABC) method. Negative controls included replacement of the primary antibodies with normal rabbit serum [1:200, DAKO] . Immunoreactivity to rat positive control specimens of the primary antibodies was determined before use.
RNA In Situ Hybridization (RNA-ISH) RNA-ISH was performed after RNAscope protocol from Advanced Cell Diagnostics (ACD). Paraffin sections were deparaffinized with Histoclear, rehydrated in graded ethanol (EtOH), and H 2 O 2 was applied for 10min at room temperature followed by 2 washes in H 2 O. Sections were placed in hot retrieval reagent and heated for 15min. After washes in H 2 O and 100% EtOH, sections were air dried. Sections were treated with protease plus for 30min at 40 C, washed with H 2 O, and incubated with target probe (p16) for 2h at 40 C. Afterwards, slides were washed with H 2 O followed by incubation with AMP1 (30min at 40 C) and next washed with wash buffer (WB) and AMP2 (15min at 40 C), WB and AMP3 (30min at 40 C), WB and AMP4 (15min at 40 C), WB and AMP5 (30min at RT) and WB, and, finally, AMP6 (15min at RT). Lastly, an RNAscope 2.5 HD Reagent kit-RED was used for chromogenic labelling. After counterstaining with haematoxylin, sections were mounted.
For analysis of cytokines (Il-6 and Cxcl1), sections were co-stained with antibodies for Plin2 and S100b. Briefly, following chromogenic labelling for cytokines, sections were washed 3 times in TBS for 5min each followed by blocking in 0.1%BSA in PBS for 30min at RT. Sections were incubated overnight with primary antibodies at 4 C. Next, sections were washed 3 times in TBS for 5min each followed by secondary antibody incubation for 1h at RT. After 3 TBS washes sections were mounted using ProLong Gold mounting media containing DAPI. Probes used: to detect p16 we used eGFP: 400281, for Il-6: 315891, and for Cxcl1:407721 (all from ADC). For all RNA-ISH experiments data were analyzed by quantifying the % of positive cells (which means each cell containing at least 1 focus was counted as positive).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean±SEM for all data. All statistical analyses including testing the normality of data distribution were performed using GraphPad Prism 7.01 and a P value <0.05 was considered as significant. The study was designed to compare changes in parameters between lean and obese animals and between obese and obese treated animals independently. All data were assessed for normality using D'Agostino & Pearson normality test (for n>7) or Shapiro-Wilk normality test (for n 7Rn>3). For differences Table S1 .
DATA AND SOFTWARE AVAILABILITY
CyTOF data (selected data, due to space restrictions) have been deposited in Mendeley: http://dx.doi.org/10.17632/w4gnsvjdf6.2. (Full data set will be provided by Yi Zhu: zhu.yi@mayo.edu).
